《高盛认股证牛熊证》保险股强势中人寿、平保领衔蓝筹 留意热门平安购16597，高杠杆中寿购16603
平保(2318)
正股表现：平保自上周二起录得四连跌，当中上周五跌约0.7%。今早则低开约0.6%後随即反弹，现报86.5元，升约2.2%，跑赢大市。有券商指由於国内代理活动率尚未完全复苏，平保上月个人新业务价值按年下跌15%，但券商仍看好其後市表现，维持「跑赢大市」评级，目标价103元。
资金流向：观察个股认股证资金流向，可见上周五资金转向部署认购证，录得约130万元资金流入。此外，今早亦见认购证获资金关注。
产品选择：投资者如看好，可留意价外幅度约9%，年期约3个月，属资金热门条款的平安购16597。贴价的选择则可留意价外幅度约6%，年期约2个月的高杠杆平安购28833。
平安购16597，行使价95.05元，2020年10月27日到期，实际杠杆15.1倍，资金热门条款
平安购28833，行使价91.93元，2020年09月25日到期，实际杠杆15.1倍，贴价、高杠杆
中人寿(2628)
正股表现：中人寿上周五升约0.7%，今早则高开约1%後升幅扩大。现报19.24元，升约6.8%，属现时升幅最大的蓝筹股。有券商料中人寿今年上半年的新业务价值可增长6.5。该行维持中人寿「跑赢大市」投资评级，目标价30元。
产品选择：投资者如看好，可考虑以行使价20至24元作为筛选认购证的条件。并可留意当中年期约5个月的低街货、低面值中寿购17632。并可留意上述行使价区域的产品中，杠杆最突出的中寿购16603。
中寿购17632，行使价23.28元，2020年12月23日到期，实际杠杆6.2倍，低街货、低面值
中寿购16603，行使价24.29元，2020年11月25日到期，实际杠杆7.5倍，行使价20至24元间产品中，杠杆最高
注: 以上数据资料来自高盛认股证牛熊证网站~
重要声明:
以上资讯由第三方提供，AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告，不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料，本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
